Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) EBT Margin (2016 - 2020)

Forte Biosciences (FBRX) has disclosed EBT Margin for 5 consecutive years, with 360.45% as the latest value for Q1 2020.

  • Quarterly EBT Margin rose 19018267.0% to 360.45% in Q1 2020 from the year-ago period, while the trailing twelve-month figure was 6214.29% through Dec 2020, up 13768651.0% year-over-year, with the annual reading at 176430.56% for FY2019, 17616855.0% down from the prior year.
  • EBT Margin for Q1 2020 was 360.45% at Forte Biosciences, up from 117588.89% in the prior quarter.
  • The five-year high for EBT Margin was 1797.8% in Q3 2016, with the low at 215711.11% in Q4 2018.
  • Average EBT Margin over 5 years is 79602.66%, with a median of 90440.0% recorded in 2017.
  • The sharpest move saw EBT Margin tumbled -20817292bps in 2019, then skyrocketed 19018267bps in 2020.
  • Over 5 years, EBT Margin stood at 1620.88% in 2016, then crashed by -6786bps to 108370.0% in 2017, then plummeted by -99bps to 215711.11% in 2018, then surged by 45bps to 117588.89% in 2019, then skyrocketed by 100bps to 360.45% in 2020.
  • According to Business Quant data, EBT Margin over the past three periods came in at 360.45%, 117588.89%, and 208166.67% for Q1 2020, Q4 2019, and Q3 2019 respectively.